Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Improved National Results with Simultaneous Liver and Kidney Transplantation using Donation after Cardiac Death Donors.

Croome KP, Mao S, Yang L, Pungpoapong S, Wadei HM, Taner CB.

Liver Transpl. 2019 Oct 9. doi: 10.1002/lt.25653. [Epub ahead of print]

PMID:
31599050
2.

Arterial blood pressure at liver transplant evaluation predicts renal histology in candidates with renal dysfunction.

Wadei HM, Abader P, Alsaad AA, Croome K, Cortese C, Xochiquetzal GJ, Khouzam S, Mai ML, Taner CB, Keaveny AP.

Liver Transpl. 2019 Oct 9. doi: 10.1002/lt.25651. [Epub ahead of print]

PMID:
31597218
3.

Acute Pancreatitis in Advanced Chronic Kidney Disease and Kidney Transplant Recipients: Results of a US Nationwide Analysis.

Kroner PT, Mareth K, Raimondo M, Lee DD, Alsaad A, Aslam N, Abader P, Wadei HM.

Mayo Clin Proc Innov Qual Outcomes. 2019 May 27;3(2):160-168. doi: 10.1016/j.mayocpiqo.2019.03.006. eCollection 2019 Jun.

4.

Transplantation of HCV-infected organs into uninfected recipients: Advance with caution.

Wadei HM, Pungpapong S, Cortese C, Alexander MP, Keaveny AP, Yang L, Taner CB, Croome KP.

Am J Transplant. 2019 Mar;19(3):960-961. doi: 10.1111/ajt.15152. Epub 2018 Nov 26. No abstract available.

PMID:
30372586
5.

Karyomegalic interstitial nephritis in a renal allograft.

Ravindran A, Cortese C, Larsen CP, Wadei HM, Gandhi MJ, Cosio FG, Sethi S.

Am J Transplant. 2019 Jan;19(1):285-290. doi: 10.1111/ajt.15035. Epub 2018 Aug 20.

PMID:
30040181
6.

Post-transplant erythrocytosis refractory to ACE inhibitors and angiotensin receptor blockers.

Vishnu P, Moreno Vanegas Y, Wadei HM, Rivera CE.

BMJ Case Rep. 2018 Jun 28;2018. pii: bcr-2018-224622. doi: 10.1136/bcr-2018-224622.

PMID:
29954763
7.

Early Allograft Dysfunction Is Associated With Higher Risk of Renal Nonrecovery After Liver Transplantation.

Wadei HM, Lee DD, Croome KP, Mai L, Leonard D, Mai ML, Taner CB, Keaveny AP.

Transplant Direct. 2018 Mar 14;4(4):e352. doi: 10.1097/TXD.0000000000000771. eCollection 2018 Apr.

8.

The impact of cold ischemia time at the higher end of the KDPI spectrum: what is the risk?

Lee DD, Wadei HM.

Transpl Int. 2018 Jul;31(7):706-707. doi: 10.1111/tri.13135. No abstract available.

9.

Behçet's syndrome and focal segmental glomerulosclerosis with nephrotic syndrome - successful treatment with etanercept
.

Leonard D, Cortese C, Wadei HM, Porter Ii IE, Aslam N.

Clin Nephrol. 2018 May;89(5):371-375. doi: 10.5414/CN109262.

PMID:
29292692
10.

Cytomegalovirus-Induced Polyarteritis Nodosa in a Liver Transplant Recipient.

Abadeer K, Aslam N, Cortese C, Wadei HM.

Am J Transplant. 2017 Dec;17(12):3236-3240. doi: 10.1111/ajt.14376. Epub 2017 Jun 30.

11.

Peripheral arterial disease preoperatively may predict graft failure and mortality in kidney transplant recipients.

Patel SI, Chakkera HA, Wennberg PW, Liedl DA, Alrabadi F, Cha SS, Hooley DD, Amer H, Wadei HM, Shamoun FE.

Vasc Med. 2017 Jun;22(3):225-230. doi: 10.1177/1358863X16689830. Epub 2017 Mar 17.

PMID:
28466760
12.

Fractional excretion of sodium in hepatorenal syndrome: Clinical and pathological correlation.

Alsaad AA, Wadei HM.

World J Hepatol. 2016 Dec 8;8(34):1497-1501. doi: 10.4254/wjh.v8.i34.1497.

13.

 Simultaneous liver and kidney transplantation in elderly patients: Outcomes and validation of a clinical risk score for patient selection.

Croome KP, Lee DD, Burns JM, Perry DK, Nguyen JH, Keaveny AP, Wadei HM, Taner CB.

Ann Hepatol. 2016 Nov-Dec 2016;15(6):870-880.

14.

Pre-orthotopic heart transplant estimated glomerular filtration rate predicts post-transplant mortality and renal outcomes: An analysis of the UNOS database.

Habib PJ, Patel PC, Hodge D, Chimato N, Yip DS, Hosenpud JD, Wadei HM.

J Heart Lung Transplant. 2016 Dec;35(12):1471-1479. doi: 10.1016/j.healun.2016.05.028. Epub 2016 Jun 7.

PMID:
27425400
15.

Simultaneous Liver Kidney Transplant (SLK) Allocation Policy Change Proposal: Is It Really a Smart Move?

Wadei HM, Gonwa TA, Taner CB.

Am J Transplant. 2016 Sep;16(9):2763-4. doi: 10.1111/ajt.13844. Epub 2016 Jun 9. No abstract available.

16.

Simultaneous liver and kidney transplantation in elderly patients: Outcomes and validation of a clinical risk score for patient selection.

Croome KP, Lee DD, Burns JM, Perry DK, Nguyen JH, Keaveny AP, Wadei HM, Taner CB.

Ann Hepatol. 2016 Nov - Dec;15(6):870-880. doi: 10.5604/16652681.1222103.

17.

Early Allograft Dysfunction After Liver Transplantation Is Associated With Short- and Long-Term Kidney Function Impairment.

Wadei HM, Lee DD, Croome KP, Mai ML, Golan E, Brotman R, Keaveny AP, Taner CB.

Am J Transplant. 2016 Mar;16(3):850-9. doi: 10.1111/ajt.13527. Epub 2015 Dec 11.

18.

Simultaneous liver-kidney transplantation from donation after cardiac death donors: is there a better way to use these organs?

Wadei HM, Taner CB.

Transplantation. 2015 Jun;99(6):e39. doi: 10.1097/TP.0000000000000704. No abstract available.

PMID:
26035275
19.

Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal.

Saull HE, Enderby CY, Gonwa TA, Wadei HM.

Clin Transplant. 2015 Jul;29(7):573-80. doi: 10.1111/ctr.12532. Epub 2015 Mar 24.

PMID:
25711849
20.

A brain-kidney connection: the delicate interplay of brain and kidney physiology.

Freeman WD, Wadei HM.

Neurocrit Care. 2015 Apr;22(2):173-5. doi: 10.1007/s12028-015-0119-8. No abstract available.

PMID:
25672972
21.

Renal outcomes of liver transplant recipients who had pretransplant kidney biopsy.

Wadei HM, Heckman MG, Rawal B, Taner CB, Mai ML, Cortese C, Rosser BG, Gonwa TA, Keaveny AP.

Transplantation. 2014 Dec 27;98(12):1323-30. doi: 10.1097/TP.0000000000000215.

PMID:
24914572
22.

Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: single-center and organ procurement and transplantation network analyses.

Wadei HM, Bulatao IG, Gonwa TA, Mai ML, Prendergast M, Keaveny AP, Rosser BG, Taner CB.

Liver Transpl. 2014 Jun;20(6):728-35. doi: 10.1002/lt.23871.

23.

Kidney disease in the setting of liver failure: core curriculum 2013.

Gonwa TA, Wadei HM.

Am J Kidney Dis. 2013 Dec;62(6):1198-212. doi: 10.1053/j.ajkd.2013.07.017. Epub 2013 Oct 4. Review. No abstract available.

PMID:
24100129
24.

Comparison of kidney function between donation after cardiac death and donation after brain death kidney transplantation.

Wadei HM, Heckman MG, Rawal B, Taner CB, Farahat W, Nur L, Mai ML, Prendergast M, Gonwa TA.

Transplantation. 2013 Aug 15;96(3):274-81. doi: 10.1097/TP.0b013e31829807d1.

PMID:
23778649
25.

Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.

Franco Palacios CR, Lieske JC, Wadei HM, Rule AD, Fervenza FC, Voskoboev N, Garovic VD, Zand L, Stegall MD, Cosio FG, Amer H.

Transplantation. 2013 Aug 27;96(4):394-9. doi: 10.1097/TP.0b013e3182977ab1.

26.

Antithymocyte globulin induction and rapid steroid taper leads to excellent results in kidney transplantation with donation after cardiac death donors: importance of rejection and delayed graft function.

Mai ML, Mai WK, Taner CB, Prendergast MB, Wadei HM, Gonwa TA.

Transplant Proc. 2013 May;45(4):1528-30. doi: 10.1016/j.transproceed.2013.01.050.

PMID:
23726612
27.

The role of the kidney in regulating arterial blood pressure.

Wadei HM, Textor SC.

Nat Rev Nephrol. 2012 Oct;8(10):602-9. doi: 10.1038/nrneph.2012.191. Epub 2012 Aug 28. Review.

PMID:
22926246
28.

Formal quality improvement curriculum and DMAIC method results in interdisciplinary collaboration and process improvement in renal transplant patients.

Leaphart CL, Gonwa TA, Mai ML, Prendergast MB, Wadei HM, Tepas JJ 3rd, Taner CB.

J Surg Res. 2012 Sep;177(1):7-13. doi: 10.1016/j.jss.2012.03.017. Epub 2012 Mar 30.

PMID:
22482757
29.

Hepatorenal syndrome: a critical update.

Wadei HM.

Semin Respir Crit Care Med. 2012 Feb;33(1):55-69. doi: 10.1055/s-0032-1301735. Epub 2012 Mar 23. Review.

PMID:
22447261
30.

Proteinuria following sirolimus conversion is associated with deterioration of kidney function in liver transplant recipients.

Wadei HM, Zaky ZS, Keaveny AP, Rosser B, Jones M, Mai ML, Bulatao I, Gonwa TA.

Transplantation. 2012 May 27;93(10):1006-12. doi: 10.1097/TP.0b013e31824bbd01.

PMID:
22357174
31.

The challenges of providing renal replacement therapy in decompensated liver cirrhosis.

Gonwa TA, Wadei HM.

Blood Purif. 2012;33(1-3):144-8. doi: 10.1159/000334149. Epub 2012 Jan 20. Review.

32.

Impact of early conversion from tacrolimus to sirolimus on chronic allograft changes in kidney recipients on rapid steroid withdrawal.

Heilman RL, Cortese C, Geiger XJ, Younan K, Wadei HM, Mai ML, Reddy KS, Gonwa TA.

Transplantation. 2012 Jan 15;93(1):47-53. doi: 10.1097/TP.0b013e3182394cb3.

PMID:
22067270
33.

Hepatorenal syndrome in the intensive care unit.

Wadei HM, Gonwa TA.

J Intensive Care Med. 2013 Mar-Apr;28(2):79-92. doi: 10.1177/0885066611408692. Epub 2011 Aug 21.

PMID:
21859679
34.

Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal.

Heilman RL, Younan K, Wadei HM, Mai ML, Reddy KS, Chakkera HA, Gonwa TA.

Transplantation. 2011 Oct 15;92(7):767-73. doi: 10.1097/TP.0b013e31822805d7.

PMID:
21775930
35.

Kidney transplantation after previous liver transplantation: analysis of the organ procurement transplant network database.

Gonwa TA, McBride MA, Mai ML, Wadei HM.

Transplantation. 2011 Jul 15;92(1):31-5. doi: 10.1097/TP.0b013e31821c1e54.

PMID:
21516062
36.

Abnormal circadian blood pressure pattern 1-year after kidney transplantation is associated with subsequent lower glomerular filtration rate in recipients without rejection.

Wadei HM, Amer H, Griffin MD, Taler SJ, Stegall MD, Textor SC.

J Am Soc Hypertens. 2011 Jan-Feb;5(1):39-47. doi: 10.1016/j.jash.2010.11.004. Epub 2011 Jan 26.

PMID:
21269908
37.

Hypertension in the kidney transplant recipient.

Wadei HM, Textor SC.

Transplant Rev (Orlando). 2010 Jul;24(3):105-20. doi: 10.1016/j.trre.2010.02.001. Epub 2010 Jun 11. Review.

PMID:
20541387
38.

Renal replacement therapy in the liver transplant candidate.

Wadei HM, Davis CL.

Adv Chronic Kidney Dis. 2009 Jul;16(4):250-5. doi: 10.1053/j.ackd.2009.05.001. Review.

PMID:
19576555
39.

Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.

Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.

Transplantation. 2009 Jan 27;87(2):227-32. doi: 10.1097/TP.0b013e31818c962b.

PMID:
19155977
40.

Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy.

Wadei HM, Geiger XJ, Cortese C, Mai ML, Kramer DJ, Rosser BG, Keaveny AP, Willingham DL, Ahsan N, Gonwa TA.

Am J Transplant. 2008 Dec;8(12):2618-26. doi: 10.1111/j.1600-6143.2008.02426.x.

41.

Thiazide diuretics: rat versus human.

Wadei HM, Haley WE.

Kidney Int. 2008 Sep;74(6):830; author reply 831. doi: 10.1038/ki.2008.275. No abstract available.

42.

Polymicrobial seminal vesical abscess in a kidney transplant recipient.

Wadei HM, Brumble L, Broderick GA, Gonwa TA.

Urology. 2008 Aug;72(2):296. doi: 10.1016/j.urology.2008.03.039. Epub 2008 May 12.

PMID:
18468658
43.

Hepatorenal syndrome: pathophysiology and management.

Wadei HM, Mai ML, Ahsan N, Gonwa TA.

Clin J Am Soc Nephrol. 2006 Sep;1(5):1066-79. Epub 2006 Jul 12. Review. No abstract available.

44.

Polyomavirus-associated nephropathy risk in kidney transplants: the influence of recipient age and donor gender.

Khamash HA, Wadei HM, Mahale AS, Larson TS, Stegall MD, Cosio FG, Griffin MD.

Kidney Int. 2007 Jun;71(12):1302-9. Epub 2007 Apr 4.

45.

Diurnal blood pressure changes one year after kidney transplantation: relationship to allograft function, histology, and resistive index.

Wadei HM, Amer H, Taler SJ, Cosio FG, Griffin MD, Grande JP, Larson TS, Schwab TR, Stegall MD, Textor SC.

J Am Soc Nephrol. 2007 May;18(5):1607-15. Epub 2007 Apr 4.

46.

Preemptive living donor kidney transplantation: do the benefits extend to all recipients?

Innocenti GR, Wadei HM, Prieto M, Dean PG, Ramos EJ, Textor S, Khamash H, Larson TS, Cosio F, Kosberg K, Fix L, Bauer C, Stegall MD.

Transplantation. 2007 Jan 27;83(2):144-9.

PMID:
17264810
47.

Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation.

Gloor JM, Cosio FG, Rea DJ, Wadei HM, Winters JL, Moore SB, DeGoey SR, Lager DJ, Grande JP, Stegall MD.

Am J Transplant. 2006 Aug;6(8):1841-7. Epub 2006 Jun 19.

48.

Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN).

Wadei HM, Rule AD, Lewin M, Mahale AS, Khamash HA, Schwab TR, Gloor JM, Textor SC, Fidler ME, Lager DJ, Larson TS, Stegall MD, Cosio FG, Griffin MD.

Am J Transplant. 2006 May;6(5 Pt 1):1025-32.

Supplemental Content

Loading ...
Support Center